{
  "symbol": "PALI",
  "company": "Palisade Bio, Inc.",
  "generated_at": "2026-06-24T07:36:51.381Z",
  "event_count": 1,
  "events": [
    {
      "type": "scout_dossier",
      "ts": "2026-06-13T01:23:07.697Z",
      "summary": "Four Form 4 filings clustered in June 2026 triggered this investigation, but upon reading the actual filing text, none represent open-market purchases. All four transactions (Wei Binxian, Donald Williams, Emil Chuang, Jordan Zwick) are RSU grants coded 'A' — equity compensation vesting as part of board appointments and annual awards. The February cluster similarly reflects RSU settlement activity for employees (Mitchell Jones/CMO and JD Finley/CEO/CFO), with code S sales only covering tax withholdings on vested shares, not directional bets. No genuine open-market insider purchase has occurred in the past 90 days. PALI is a pre-revenue micro-cap biotech ($297M market cap) with $133M cash burning ~$10M/quarter in R&D; it has no products approved and its sole lead asset (PALI-2108) just completed Phase 1b. A Phase 2 UC trial starting Q3 2026 is the primary near-term catalyst. The stock trades at $1.71, well off its 52-week high of $2.86; technicals are bearish with MACD below signal and RSI in neutral territory at ~40.",
      "verdict": "no_anomaly",
      "confidence": 4,
      "tool_calls": 20,
      "walltime_min": 12,
      "debug_path": "dossiers/2026-06-13-PALI.scout.debug.json"
    }
  ],
  "lessons": [],
  "chart_signal": {
    "ticker": "PALI",
    "call": "HOLD",
    "confidence": 2,
    "score": 3,
    "factors": {
      "above_200dma": "+2",
      "below_50dma": "-1",
      "momentum_strong_up": "+2 (171.6%)",
      "rsi_neutral": "0 (54.4)",
      "macd_above_signal": "+1",
      "recent_macd_bullish_cross": "+1 (2d ago)",
      "broken_below_high": "-2 (-30.7% from high)"
    },
    "summary": "HOLD (score +3) · 12-1 mom 171.6% · RSI 54.4 · above_200_only · -30.7% from high",
    "last_close": 1.94,
    "one_month_ago_close": 2.01,
    "twelve_month_ago_close": 0.74,
    "twelve_one_momentum_pct": 171.62,
    "rsi_14": 54.4,
    "ma_stack": "above_200_only",
    "from_period_high_pct": -30.71,
    "period_high": 2.8,
    "price_targets": {
      "bear": 1.79,
      "fair": 4.54,
      "bull": 25,
      "bear_return_pct": -7.7,
      "fair_return_pct": 134.3,
      "bull_return_pct": 1188.7,
      "method": "street_targets ⨯ chart_floors",
      "street": {
        "target_low": 5,
        "target_mean": 9.71429,
        "target_high": 25,
        "analyst_count": 7
      }
    },
    "generated_at": "2026-06-24T07:36:51.377Z"
  }
}